Publication Name	World Journal of Transplantation
Manuscript ID	47671
Country	United States

Received	2019-03-21 05:55
Peer-Review Started	2019-03-24 11:40
To Make the First Decision	2019-04-12 00:31
Return for Revision	2019-04-19 09:46
Revised	2019-07-10 12:15
Second Decision	2019-07-17 03:12
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2019-07-17 03:37
Articles in Press	2019-07-17 03:37
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2019-07-29 08:23
Publish the Manuscript Online	2019-07-30 03:36

ISSN	2220-3230 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Immunology
Manuscript Type	Minireviews
Article Title	Considerations for hematopoietic stem cell transplantation in primary immunodeficiency disorders
Manuscript Source	Unsolicited Manuscript
All Author List	Tatyana Gavrilova
ORCID	Author(s) ORCID Number Tatyana Gavrilova http://orcid.org/0000-0001-8428-5944
Funding Agency and Grant Number
Corresponding Author	Tatyana Gavrilova, MD, Assistant Professor, Division of Allergy and Immunology, Montefiore Medical Center, 1525 Blondell Avenue, Bronx, NY 10461, United States. tgavrilo@montefiore.org
Key Words	Primary immunodeficiency disorders; Hematopoietic stem cell transplant; Autoimmunity; Conditioning regimens; ;
Core Tip	Primary immunodeficiency disorders (PID) result from inborn errors in immunity and hematopoietic cell transplant (HCT) still remains as the only curative option for many of these disorders. Severe combined immunodeficiency disorders belong to a subtype of PID that constitutes a medical emergency and requires HCT within weeks from the time of birth. Donor selection, conditioning regimen and outcomes of immune reconstitution vary greatly among these disorders. This manuscript reviews some of the unique elements of HCT in PID and evidence-based approaches to transplant in patients with these rare and complex disorders.
Publish Date	2019-07-30 03:36
Citation	Gavrilova T. Considerations for hematopoietic stem cell transplantation in primary immunodeficiency disorders. World J Transplant 2019; 9(3): 48-57
URL	https://www.wjgnet.com/2220-3230/full/v9/i3/48.htm
DOI	https://dx.doi.org/10.5500/wjt.v9.i3.48

Full Article (PDF)	WJT-9-48.pdf
Full Article (Word)	WJT-9-48.docx
Manuscript File	47671-Review.docx
Answering Reviewers	47671-Answering reviewers.pdf
Audio Core Tip	47671-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	47671-Conflict-of-interest statement.pdf
Copyright License Agreement	47671-Copyright license agreement.pdf
Peer-review Report	47671-Peer-review(s).pdf
Scientific Misconduct Check	47671-Scientific misconduct check.pdf
Scientific Editor Work List	47671-Scientific editor work list.pdf